NCT01007305

Brief Summary

This is a pilot study to assess the feasibility of conducting a randomized, blinded, controlled trial of bilateral salpingo-oophorectomy (BSO, removal of the ovaries and fallopian tubes) versus ovarian conservation among premenopausal women age 40 years and greater who plan to undergo hysterectomy for a benign gynecologic condition. Subjects will be randomized to BSO or ovarian conservation concomitant with hysterectomy and remain blinded to group assignment. The primary goal of this pilot is to determine the feasibility of recruiting and retaining study participants in anticipation of conducting a larger, multi-centered trial. However, the investigators will also obtain baseline data and follow-up measures at 6 weeks and 6 months after surgery. Outcomes will be assessed in several domains that the investigators hypothesize may be effected by oophorectomy: cardiovascular health, skeletal health, sexual functioning, and health-related quality-of-life.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 2009

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Last Updated

August 5, 2011

Status Verified

November 1, 2009

Enrollment Period

1.9 years

First QC Date

November 3, 2009

Last Update Submit

August 4, 2011

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment rate

    start of study

  • Flow-mediated diameter of the brachial artery

    Baseline and 6 months follow-up

  • Serum bone turnover markers

    Baseline and 6 months follow-up

  • Sexual functioning and quality-of-life questionnaires

    Baseline and 6 month follow-up

Study Arms (2)

Bilateral salpingo-oophorectomy

EXPERIMENTAL

Removal of both ovaries and fallopian tubes at the time of hysterectomy for benign conditions.

Procedure: Bilateral salpingo-oophorectomy

Ovarian conservation

ACTIVE COMPARATOR

No ovaries or fallopian tubes removed at the time of hysterectomy for benign conditions.

Procedure: Ovarian conservation

Interventions

Removal of both ovaries and fallopian tubes at the time of hysterectomy

Bilateral salpingo-oophorectomy

Both ovaries and fallopian tubes not removed at the time of hysterectomy

Ovarian conservation

Eligibility Criteria

Age40 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Plans to undergo hysterectomy for any non-cancerous gynecologic condition, including symptomatic fibroids, abnormal bleeding, pelvic pain, or pelvic organ prolapse. Hysterectomy may be done abdominally, vaginally or laparoscopically
  • Premenopausal defined as having at least one menses in the 3 months prior to surgery
  • Age \> or = 40 years
  • Speaks English or Spanish

You may not qualify if:

  • Personal or family history of breast and/or ovarian cancer (at least one first degree relative with a diagnosis of breast or ovarian cancer) or a known BRCA mutation
  • Known or suspected adnexal mass by physical exam or radiologic imaging study
  • Gynecologist recommends BSO for treatment of pelvic pain and/or endometriosis
  • Known history of coronary heart disease defined as any of the following: prior myocardial infarction, history of angioplasty, history of angina, admission to the hospital for evaluation of chest pain, or use of nitroglycerin to treat angina
  • History of stroke
  • History of osteoporosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Location

University of California, Sans Francisco

San Francisco, California, 94115, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 3, 2009

First Posted

November 4, 2009

Study Start

May 1, 2009

Primary Completion

April 1, 2011

Last Updated

August 5, 2011

Record last verified: 2009-11

Locations